NKX2-1 and cancer: In conclusion, we identified the homeodomain transcription factor NKX2–1 as a novel direct oncogenic inducer of serine/glycine synthesis enzymes in cancer, and we characterised downstream consequences on cellular nucleotide, redox and lipid metabolism and DNA methylation.